These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29279284)

  • 21. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.
    Guevara S; Abdelnour A; Soley C; Porat N; Dagan R; Arguedas A
    Vaccine; 2012 Jun; 30(26):3857-61. PubMed ID: 22521846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland.
    Quirk SJ; Haraldsson G; Hjálmarsdóttir MÁ; van Tonder AJ; Hrafnkelsson B; Bentley SD; Haraldsson Á; Erlendsdóttir H; Brueggemann AB; Kristinsson KG
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the 13-valent pneumococcal conjugate vaccine on Streptococcus pneumoniae multiple serotype carriage.
    Valente C; Hinds J; Gould KA; Pinto FR; de Lencastre H; Sá-Leão R
    Vaccine; 2016 Jul; 34(34):4072-8. PubMed ID: 27325351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
    Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E
    Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong.
    Ho PL; Chiu SS; Law PY; Chan EL; Lai EL; Chow KH
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):145-8. PubMed ID: 25483278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
    Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization.
    Nzenze SA; Shiri T; Nunes MC; Klugman KP; Kahn K; Twine R; de Gouveia L; von Gottberg A; Madhi SA
    Pediatr Infect Dis J; 2013 Nov; 32(11):1270-8. PubMed ID: 24061271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptococcus pneumoniae Serotypes 9 and 14 Circulating in Brazil over a 23-Year Period Prior to Introduction of the 10-Valent Pneumococcal Conjugate Vaccine: Role of International Clones in the Evolution of Antimicrobial Resistance and Description of a Novel Genotype.
    Pinto TC; Kegele FC; Dias CA; Barros RR; Peralta JM; Merquior VL; Carvalho MD; Chochua S; Hawkins P; McGee L; Teixeira LM
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6664-6672. PubMed ID: 27572394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme.
    Wouters I; Van Heirstraeten L; Desmet S; Blaizot S; Verhaegen J; Goossens H; Van Damme P; Malhotra-Kumar S; Theeten H;
    Vaccine; 2018 Jan; 36(1):15-22. PubMed ID: 29180027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine.
    Payeras A; Villoslada A; Garau M; Salvador MN; Gallegos MC
    Int J Infect Dis; 2015 Apr; 33():22-7. PubMed ID: 25541296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.
    Olarte L; Kaplan SL; Barson WJ; Romero JR; Lin PL; Tan TQ; Hoffman JA; Bradley JS; Givner LB; Mason EO; Hultén KG
    J Clin Microbiol; 2017 Mar; 55(3):724-734. PubMed ID: 27847379
    [No Abstract]   [Full Text] [Related]  

  • 36. Pneumococcal carriage among children after four years of routine 10-valent pneumococcal conjugate vaccine use in Brazil: The emergence of multidrug resistant serotype 6C.
    Neves FPG; Cardoso NT; Snyder RE; Marlow MA; Cardoso CAA; Teixeira LM; Riley LW
    Vaccine; 2017 May; 35(21):2794-2800. PubMed ID: 28431817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype replacement of Streptococcus pneumoniae due to seven-valent pneumococcal conjugate vaccine in Japan.
    Sakata H; Sato Y; Toyonaga Y; Hanaki H;
    Pediatr Int; 2018 Jan; 60(1):52-56. PubMed ID: 28779495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease.
    Hammitt LL; Bruden DL; Butler JC; Baggett HC; Hurlburt DA; Reasonover A; Hennessy TW
    J Infect Dis; 2006 Jun; 193(11):1487-94. PubMed ID: 16652275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.
    Gladstone RA; Jefferies JM; Tocheva AS; Beard KR; Garley D; Chong WW; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2015 Apr; 33(17):2015-21. PubMed ID: 25776920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.